Viral Inf of Circ, Lymph, and Res Flashcards

1
Q

Epstein Barr Virus – Virology

A
  • Herpesviridae family member
  • Enveloped
  • dsDNA virus
  • Uses C3d component of complement system for attachment and entry.
  • Replication in epithelial and B-cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Heterophile Antibodies

A

random antibodies produced by B-cells “animal antibodies”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Latent Membrane Protein 1 (LMP1)

A
  • Genes Involved in EBV Carcinogenesis
  • 6 transmembrane-spanning domains
  • CD40 Homologue
  • Constitutively Active Receptor
  • Increased Growth and Suppressed Apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Latent Membrane Protein 2 (LMP2)

A
  • Genes Involved in EBV Carcinogenesis

- Increased Growth of B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epstein Barr Virus Nuclear Antigen 1 (EBNA1)

A
  • Genes Involved in EBV Carcinogenesis
  • Transactivation of EBV transforming genes
  • Inhibition of Apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epstein-Barr Virus - transmission:

A

-saliva

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Infectious Mononucleosis - causative agent:

A

Epstein-Barr Virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Infectious Mononucleosis -

A
  • Symptoms: fever, malaise, exudative pharyngitis, splenomegaly,tender lymphadenitis
  • Biochemical Marker: Heterophile antibodies
  • Epidemiology:Most common in young adulthood in industrialized countries.
  • Complication: splenic rupture
  • Pathogenesis: immune targeting of the infected B cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ampicillin and mono results in

A

a rash!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Infectious Mononucleosis Clinical Time course

A
  • 2 months for symptom onset
  • fever, malaise, fatigue
  • lymphadenopathy and hepatosplenomegaly
  • pharyngitis - pretty severe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Infectious Mononucleosis - serologic

A

-can first detect: EA = EBV Early Antigen (lytic)
and VCA = EBV Viral Capsid Antigen (lytic)
-later can detect: EBNA = Epstein Barr Nuclear Antigen (latent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Infectious Mononucleosis - diagnosis

A
  • Antibodies to EBV: IgM to Viral Capsid Antigen (VCA) demonstrates primary EBV infection.
  • Mono Spot test: Heterophile Antibodies : agglutinate sheep or horse RBC.
  • -Downey Cells: Atypical T cell; Vacuoles; Altered Nucleus; Indented Cell Margin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Infectious Mononucleosis: Treatment & Prevention

A
  • No human vaccine approved yet.
  • Rest and Hydration
  • Anti-virals (acyclovir) inhibit the viral polymerase, but have little impact on the outcome of clinical illness.
  • Avoid strenuous activity to avoid splenic rupture.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oral hairy leukoplakia

A
  • EBV Manifestations
  • Active EBV replication =white patches on tongue
  • Primarily Immunocompromised, e.g., HIV infection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Oral hairy leukoplakia treatment

A
  • Antiherpetic drugs

- Podophyllin resin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Burkitt’s Lymphoma

A
  • EBV Manifestations
  • B-cell origin
  • Often presenting in the jaw of children (endemic form)
  • specific chromosome translocation (8 to 14) = overtranscription of myc gene –> cell cycle regulator = cell proliferation
  • Co-factors: Chronic Malaria – endemic & Immune Suppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hodgkin’s Disease info/pateint presentation

A
  • EBV Manifestations
  • Not linked to specific chromosomal translocation events.
  • Patient presentation:Nontender, palpable, lymphandenopathy in neck supraclavicular, and/or axilla. Commonly enlargement of lymph nodes deep within chest (medistinal adenopathy). Approximately 1/3 of patients display fever, night sweats, and weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

hallmark of Hodgkins disease

A

-Reed-Sternberg cell: a large cell with two or more nuclei or nuclear lobes, each of which contains a large eosinophilic nucleolus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hodgkin’s Disease treatment

A
  • Treatment with radiotherapy and/or chemotherapy.

- Can be cured in over 90% of patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nasopharyngeal Carcinoma info/symptoms

A
  • EBV Manifestations
  • Originates in the nasopharynx.
  • Epithelial cell cancer.
  • Symptoms: Facial pain; Fullness in sinuses and throat; Hearing loss
  • Cofactors: Genetics & Diet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Nasopharyngeal Carcinoma - treatment and prevention:

A

Nasopharyngeal carcinomas are treated through chemotherapy and radiation treatment regimens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Post-transplantation Lymphoproliferative Disorder (PTLD) - what is it info/symptoms

A
  • EBV Manifestations
  • Abnormal proliferation of lymphoid cells in a transplant patient.
  • Symptoms: fever, fatigue, weight loss, or progressive encephalopathy
  • Benign or Malignant
  • EBV infection at time of transplant = major risk factor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Post-transplantation Lymphoproliferative Disorder (PTLD)- diagnosis

A
  • Histological analysis of tissue.

- Detection of EBV genomes (in situ hybridization)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Post-transplantation Lymphoproliferative Disorder (PTLD) - treatment

A
  • 1st Reduce Immunosuppression
  • 2nd Treatment with Rituximab (mouse human chimeric anti-CD20 antibody.)
  • 3rd conventional chemotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Cytomegalovirus Disease presentation in patients
- depends on patient demographics - normal immune status indiv: asymptomatic carrier or mono-like symptoms (distinct from EBV bc heterophile AB negative& no EBV antigens) - baby of seronegative mother: prior to birth --> cytomegalic inclusion disease - immunodef/AIDS population: Multisite symptomatic disease
26
Cytomegalovirus (CMV) -Virology
- Herpesviridae family - Enveloped - dsDNA - Viral Replication: 1. Mucosal epithelium 2. Viremia (highest risk of spread to others) - Latency in monocyte - Reactivation is rarely symptomatic in immunocompetent individuals.
27
Cytomegalovirus (CMV) - transmission
- Saliva - Breast milk - Urine - Fomites - Sexual contact
28
Cytomegalovirus (CMV) - diagnosis
- Detection of viral DNA or virus culture from diseased tissue.: Note: Virus may be shed from urine or saliva for months to years after acute infection. Not necessarily diagnostic of acute. - Seroconversion: ***Timing and multiple samples needed to differentiate recent from current infection.
29
Cytomegalovirus (CMV) - treatment
---1st--- -Gancyclovir: converted to viral polymerase inhibitor by CMV enzymes (i.v. or oral). -Valganciclovir: converted to gancyclovir within the body. Increased bioavailability. (oral) -Toxicity: Bone marrow toxicity, drug-related neutropenia. ---2nd--- -Cidofovir: converted to viral polymerase inhibitor by cellular enzymes. More toxic than gancyclovir.(i.v.) -Foscarnet: direct inhibitor of the CMV polymerase. renal toxicity. (i.v.) (ACYCLOVIR AND VALACYCLOVIR = NO GOOD)
30
Cytomegalovirus (CMV) - symptoms
``` -Mono-like: most mild outcome of CMV infection Fever Fatigue Pharyngitis (usually non exudative) Abnormal T cells No heterophile antibody production (ONLY PRIMARY INF WITH CMV) ```
31
Cytomegalic Inclusion Body Disease - symptoms
-Cytomegalovirus (CMV) manifestation -Most common with primary infections -Hepatosplenomegaly Jaundice Petechiae/Rash
32
Cytomegalic Inclusion body Disease - treatment/prevention
- Prevention (primarily for seronegative pregnant women) - Interrupt CMV transmission in body fluids (children are frequent shedders of CMV) - Handwashing - Avoid sharing drinks and toothbrushes with young children - Avoid contact with saliva when kissing a child - Treatment - Maternal treatment with CMV immunoglobulin during pregnancy (currently under investigation)
33
CMV in Immunosuppressed Populations
-Most important and common viral pathogen complicating organ transplant. Highest risk – 1- 4 mo. following transplant. -AIDS patients present with CMV diseases usually with highly advanced disease -CD4 counts between 50 and 100 cells/μL Spiking Fever (100- 104 ºF) -Sources: Transplanted Organ, reactivation of latent CMV
34
CMV in transplant recipients:
-CMV pneumonitis -Symptoms: Fever; Hypoxia; Interstitial Lung Infiltrates -GI tract -Symptoms: Diarrhea; Abdominal Pain Nausea; Vomiting --> Complication: perforation and hemorrhage of GI epithelium -Graft vs. Host Disease
35
CMV in AIDS patients
- ----CMV Retinitis: Symptoms: Blurred Vision; “Floaters”; White lesions --> Lesions with irregular, white necrotic border - Diagnosis: Pupil dilation and ophthalmoscope examination - ---GI tract - ---CMV pneumonitis
36
Limiting CMV spread
- Organ transplant prevention - Donor matching - Prophylaxis or preemptive therapy with antivirals - CMV immunoglobin - AIDS Prevention: Maintenance therapy with antivirals when reaching a threshhold level of CD4+ T-cells. - Treatment Indications: immunocompromised patients with severe disease are treated with I.V. antivirals.
37
Myocarditis definition
inflammation of the middle muscular layer of the heart wall leading to ventricular dysfunction.
38
Viral Myocarditis - who is most likely to get and symptoms:
- Most prevalent in adult men. - Typical presentation: Shortness of breath; Exercise intolerance; Fatigue - May mimic cardial infarction
39
most common viral genome found within myocarditis tissue:
historicaly: -adenoviruses (especially types 2 &5) -enteroviruses (especially coxsackievirus B) more recently: B19 parvovirus & HHV-6
40
Viral Myocarditis - diagnosis
- High index of suspicion in patients with congestive heart failure of unknown origin. - Chest Radiograph, electrocardiogram, endomyocardial biopsy. - Nucleic acid based test on the biopsied material may reveal viral cause.
41
Viral Myocarditis - management/treatment
- Manage symptoms of CHF and arrhythmias | - Mild disease --> bed rest and observation
42
Mumps - symptoms
- Swollen, tender parotid glands - Sometimes accompanied by submandibular gland swelling. - Prodrome of malaise and anorexia (1-2 days).
43
Mumps virus - virology
- Paramyxoviridae family. - ssRNA genome. - One serotype - Incubation period is 14-18 days. - Age of onset usually between 5-14 years. (in pre-vaccine era) - 20% of infections are asymptomatic.
44
Mumps virus - complications
- Meningitis (15% of mumps cases) - Orchitis (testicular inflammation) common in postpubertal males. Rarely affects fertility. - Deafness in 1/20,000 mumps cases. - Myocarditis (extremely rare, but often fatal)
45
Mumps virus - lifecycle:
- entry into respiratory tract - spreads into local lymph nodes - primary viremia established - sperad to salivary glands, teste,ovaries, pancreas, CNS - more viremia - generalized spread to other body sites including kidneys - more viremia
46
Mumps virus - diagnosis
-swelling of parotid gland or other salivary gland without any other reason is enough
47
Mumps virus - treatment
if uncomplicated will resolve on its own
48
Mumps Virus - transmission
- Direct contact - respiratory droplets - saliva - contaminated fomites
49
Mumps Virus - prevention
- live attenuated -- Intramuscular | - recommended for all children
50
MMRV vaccine consists of and dosing schedule:
-Mumps -Measles -Rubella -Varicella 2 doses 12-15mo and 4-6 years
51
mumps vaccine for adults
- all adults one done | - 2 doses for high risk exposure
52
Kaposi’s Sarcoma (KS) lesion info
- --Cutaneous Lesions: - Pink, Purple, or Brown in Color - Usually non-painful - Can become confluent (combine into one giant lesion) - Increased proliferation of endothelial cells.* - --Cases with visceral lesions: Weight loss or fever - --Histology: Spindle morphology of cells
53
Kaposi’s Sarcoma (KS) - Classic type
rare middle eastern or miditerranean few lesions -not life threatening
54
Kaposi’s Sarcoma (KS) - endemic type
- equatorial africa - Presents like Classic KS - Aggressive form in pre-pubrescent children, often fatal within 3 years
55
Kaposi’s Sarcoma (KS) - transplant related type
- Occurs in individuals whose immune systems have been suppressed following organ transplant. - Often lesions resolve when immunosuppressive therapy is discontinued (or modified).
56
Kaposi’s Sarcoma (KS) - AIDS related type
- Often more widespread lesions than other KS forms. - May include other symptoms - Lymph node swelling - Fever - Weight loss - Often fatal when lung involvement occurs
57
Kaposi’s Sarcoma (KS) - what casuses it?
Herpes virus 8 (HHV-8)
58
Human Herpes Virus 8 (HHV-8) - Virology
(-causes Kaposi’s Sarcoma) - Enveloped - dsDNA genome - Latent state in KS lesions - Contains several homologues of cellular genes.
59
Human Herpes Virus 8 (HHV-8) - transmission
-blood borne - needle, sex
60
HHV-8 – Treatment and Prevention
- Prevention of HHV-8 transmission: Safe sex practices; Limit needle sharing - Treatments for KS: Often controlling immune deficiency higher priority that treating KS.;Not herpes antivirals because virus is in the latent state in KS lesions.; Treatment can be with chemotherapy, radiation, and/or surgery.
61
Adult T-cell Lymphoma (ATL) - what virus? Presentation?
- caused by human t-cell lymphoma virus-1 - T-cell origin - --Clinical presentation:--- - Lymphadenopathy - Hepatosplenomegaly - Hypercalcemia - Skin infiltration of tumor cells: Papules; Plaques; Tumors; Ulcers
62
Adult T-cell Lymphoma (ATL) appearance in cells:
"flower cells!"
63
Adult T-cell Lymphoma (ATL) - who gets most, where most prevalent?
- Disease most common in southern Japan, the Caribbean, and Central Africa. - Median age of onset = 55 years
64
Adult T-cell Lymphoma - dagnosis:
Serology: antibodies to Human T-cell leukemia virus 1 (HTLV-I).
65
HTLV-1 Associated Myelopathy (HAM)/Tropic Spastic Paraparesis - what happens? what virus?
- caused by human t-cell lymphoma virus-1 - Demyelination of neurons within the spinal cord. - Likely autoimmune disease
66
HTLV-1 Associated Myelopathy (HAM)/Tropic Spastic Paraparesis - who is affected most? symptoms?
- Highest incidence adult women - Symptoms: Stiff gait ; Lower extremity; weakness, back pain; Incontinence; 1/3 patients bedridden at 10 yr post diagnosis
67
Human T-cell Leukemia Virus I (HTLV-I) - virology
-Infects CD4 and CD8 positive cells -Retrovirus -Enveloped +ssRNA genome -Reverse transcription
68
HTLV Life Cycle
- gets in via glut1 receptor - reverse transcriptase to make dsDNA from its +ssrNA - integrate into genome - transcribed = mRNA and protein - maturation step with budding
69
HTLV-I - transmission
- Nursing - Blood transfusion - Sexual transmission (Male to Female more efficient)
70
HTLV-I – Treatment and Prevention
- Nursing discouraged in endemic areas. - Screening the blood supply - Reduce unprotected sex - Treatment with combined chemotherapy, however limited effectiveness.